1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Antibacterial Drugs Market 2015-2019

Global Antibacterial Drugs Market 2015-2019

  • November 2015
  • -
  • Infiniti Research Limited
  • -
  • 116 pages

Summary

Table of Contents

Search Inside

About antibacterial drugs
Antibacterial drugs are chemical compounds used to treat infections caused by bacteria either by killing or inhibiting the growth of bacteria. The term antibiotic is often used synonymously with an antibacterial. However, antibiotics are agents that work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. The term antibiotic was originally coined to refer to any compound of microbial origin, which is antagonistic to the growth of the microbe. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. They can be bacteriostatic or bactericidal in nature, i.e., they either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad-spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).

Technavio's analysts forecast the global antibacterial drugs market to grow at a CAGR of 1.06% over the period 2014-2019.

Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global antibacterial drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various prescription drugs along with the generic drugs used for the treatment of various infectious diseases caused by the different strains of bacteria. The various classes of antibacterial drug included in this report are beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, folate antagonists, tetracyclines, and other miscellaneous agents, which include glycopeptides, nitroimidazoles, lincosamides, lipopeptides, nicotinic acid derivatives, and polypeptide antibiotics.

Technavio's report, Global Antibacterial Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global antibacterial drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- Allergan
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Teva Pharmaceuticals

Other prominent vendors
- Abbott
- Achaogen
- Actelion
- AmpliPhi Biosciences
- Aspen Pharmacare
- Astellas
- AstraZeneca
- Aurobindo Pharma
- Baxter
- Basilea Pharmaceuticals
- Bayer
- Biocon
- Bristol-Myers Squibb
- Cempra
- Cipher Pharmaceuticals
- Corden Pharma
- Cornerstone Therapeutics
- Eli Lilly
- Exoxemis
- F. Hoffmann-La Roche
- Flynn Pharma
- Hospira
- Incepta Pharmaceuticals
- InSite Vision
- Insmed Incorporated
- Johnson & Johnson
- KaloBios Pharmaceuticals
- Kyorin Pharmaceutical
- Lupin Pharmaceuticals
- Lytix Biopharma
- Melinta Therapeutics
- Mylan
- Nektar
- Orchid Pharma
- Par Pharmaceutical
- Paratek Pharmaceuticals
- Pernix Therapeutics
- PTC Therapeutics
- RedHill Biopharma
- Sagent Pharmaceuticals
- Sanofi
- Shionogi
- Starpharma
- Sun Pharmaceutical
- Symbiomix
- Takeda Pharma
- Tetraphase Pharmaceuticals
- Theravance Biopharma
- The Medicines Company
- Valneva
- Wockhardt Global Solutions

Key market driver
- Special regulatory designations
- For a full, detailed list, view our report

Key market challenge
- Development of drug-resistant strains
- For a full, detailed list, view our report

Key market trend
- Strategic alliances and M&A
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Infectious Disease Drugs: The Chinese Market

Infectious Disease Drugs: The Chinese Market

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Assess market dynamics of Chinese market for both communicable and - non-communicable infectious disease drugs, their opportunities and restraints. - Evaluate Chinese drug market ...

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance Summary The antibacterial drug market covers ...

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • $ 4995
  • Industry report
  • March 2017
  • by GBI Research

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market Summary Respiratory complications are a ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.